{"nct_id":"NCT01984697","title":"A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2013-12-12","start_date_type":"ACTUAL","primary_completion_date":"2015-06-19","primary_completion_date_type":"ACTUAL","completion_date":"2017-07-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}